Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line
Yvonne de Jong(Leiden University Medical Center), Judith V.M.G. Bovée(Leiden University Medical Center)
Cited by 34
Related Papers
Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation
|British Journal of Cancer|2018|61
Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
|Oncogenesis|2018|57
Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
|BMC Cancer|2012|43
Targeting survivin as a potential new treatment for chondrosarcoma of bone
|Oncogenesis|2016|34